LianBio (LIANY)
OTCMKTS · Delayed Price · Currency is USD
0.0910
0.00 (0.00%)
Feb 12, 2026, 9:30 AM EST
LianBio Market Cap
LianBio has a market cap or net worth of $9.84 million as of February 12, 2026. Its market cap has decreased by -67.50% in one year.
Market Cap
9.84M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.09
Market Cap Chart
Since November 1, 2021, LianBio's market cap has decreased from 1.44B to 9.84M, a decrease of -99.32%. That is a compound annual growth rate of -68.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 9.86M | -4.00% |
| Dec 31, 2025 | 10.28M | -64.15% |
| Dec 31, 2024 | 28.66M | -94.07% |
| Dec 29, 2023 | 483.04M | 171.83% |
| Dec 30, 2022 | 177.70M | -73.10% |
| Dec 31, 2021 | 660.59M | -54.19% |
| Nov 1, 2021 | 1.44B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HOOKIPA Pharma | 13.12M |
| TRON Group | 11.43M |
| Inhibitor Therapeutics | 10.01M |
| Biomind Labs | 8.84M |
| AccuStem Sciences | 8.74M |
| Curative Biotechnology | 7.94M |
| NKGen Biotech | 7.84M |
| Synlogic | 7.28M |